TROVE2 is a biotinlyated natural protein having a molecular mass of 58kDa. TROVE2 is purified from bovine tissues by protein-chemical methods.
TROVE2, a biotinylated natural protein with a molecular weight of 58kDa, is derived from bovine tissues and purified using specialized protein-chemical techniques.
TROVE2 is provided in a buffer solution composed of 20mM HEPES (pH 8.0), 150mM NaCl, and 20% glycerol.
For short-term storage (up to 2-4 weeks), TROVE2 should be kept refrigerated at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To maintain product integrity, it is crucial to minimize freeze-thaw cycles.
SDS-PAGE analysis indicates a purity level exceeding 83.0%.
60 kDa SS-A/Ro ribonucleoprotein, 60 kDa ribonucleoprotein Ro, RoRNP, 60 kDa Ro protein, Ro 60 kDa autoantigen, TROVE domain family member 2, Sjoegren syndrome type A antigen, SS-A, Sjoegren syndrome antigen A2, TROVE2, RO60, SSA2, RO-60.
Bovine tissues.
Bovine TROVE2 (TELOMERASE, Ro, and VAULT domain family member 2) is a 60 kDa RNA-binding protein that forms complexes with small cytoplasmic RNA molecules known as Y RNAs. It functions primarily to stabilize these RNAs from degradation. TROVE2 is also known by several synonyms, including 60 kDa SS-A/Ro ribonucleoprotein, RoRNP, Ro 60 kDa autoantigen, Sjoegren syndrome type A antigen (SS-A), and Sjoegren syndrome antigen A2 .
The protein has significant clinical relevance as sera from patients with Systemic Lupus Erythematosus (SLE) often contain antibodies that react with the normal cellular TROVE2 protein as if it were a foreign antigen . For research applications, bovine TROVE2 is typically purified from bovine tissues using protein-chemical methods and has a molecular mass of approximately 60 kDa .
Biotin (vitamin B7) is a critical coenzyme in bovine systems that plays essential roles in metabolic processes, particularly in carboxylation reactions. It functions as a cofactor for several carboxylase enzymes that are central to fatty acid metabolism, amino acid metabolism, and gluconeogenesis. These biotin-dependent carboxylases include acetyl-CoA carboxylase, propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and pyruvate carboxylase .
In bovine physiology, biotin has demonstrated significant effects on claw health and development. Research has shown that biotin supplementation increases serum biotin levels and significantly increases claw hardness in cattle . This has practical implications for managing vertical fissures and other claw-related issues in cattle populations.
The standard methodology for isolating bovine TROVE2 involves protein-chemical purification techniques from bovine tissues. The protein is typically prepared as a sterile filtered clear solution with greater than 80% purity as determined by SDS-PAGE analysis .
For laboratory applications, TROVE2 is commonly formulated in a buffer containing 20mM Tris/HCl at pH-7.5, 150mM NaCl, 2mM MgCl2, 0.2mM DTT, 0.1mM PMSF, and 20% glycerol to maintain stability . This formulation preserves the protein's structural integrity and functional properties during storage and experimentation.
For optimal stability, bovine TROVE2 should be stored at 4°C if the entire vial will be used within 2-4 weeks. For longer-term storage, the protein should be kept frozen at -20°C, with careful attention to avoiding multiple freeze-thaw cycles that could compromise structural integrity .
Biotin supplementation has demonstrable positive effects on claw horn growth in bovine models. In a controlled study with young Girolando cattle, animals receiving 12.5 mg of biotin daily for 40 consecutive days showed significantly enhanced hoof growth compared to control animals. The biotin-supplemented group exhibited an average hoof growth of 11.3 ± 0.72 mm, while the control group showed only 7.2 ± 0.78 mm of growth (p < 0.001) .
This finding contradicts earlier assumptions that ruminants synthesize sufficient B-complex vitamins through ruminal biota to meet their physiological needs. The research indicates that supplemental biotin can enhance keratinization processes and promote hoof development even in clinically healthy animals .
When designing experiments to study biotin's effects on cattle claw health, several methodological considerations are crucial:
Control group design: Implement a properly randomized allocation of animals to treatment and control groups to minimize confounding variables. The experimental design should include identical mineral supplements between groups, differing only in biotin content .
Duration of supplementation: Long-term studies are necessary to observe significant effects. In clinical field trials with Hereford beef cows, meaningful differences in vertical fissure prevalence were observed only after 18 months of continuous supplementation .
Dosage optimization: Effective dosages typically range from 10-12.5 mg/head/day for cattle. Careful dosage determination is essential for valid results .
Measurement standardization: Implement standardized measurement techniques for assessing claw growth and hardness. In growth studies, creating reference demarcation points on the hoof and measuring at consistent intervals (e.g., days 0, 20, and 40) provides reliable data .
Health status assessment: Conduct thorough baseline clinical and laboratory evaluations of study animals, including complete blood counts and biochemical profiles (aspartate aminotransferase, alkaline phosphatase, creatinine, and creatine kinase) to ensure subjects are clinically healthy .
Biotin interference represents a significant methodological challenge in laboratory immunoassays, particularly when working with biotinylated proteins like TROVE2. The degree of interference varies depending on biotin concentration and the specific assay platform. Researchers should consider the following approaches to mitigate biotin interference:
Assay selection: Different immunoassay platforms exhibit varying susceptibilities to biotin interference. For example, at 400 ng/mL biotin concentration, the Siemens LOCI and Roche Elecsys free T4 assays showed dramatically different positive biases of 26% and 1146%, respectively . Selecting assay platforms with lower biotin sensitivity for specific analytes can minimize interference.
Interference quantification: Perform in vitro studies to quantify the extent of biotin interference in your specific assay system. For instance, TSH immunoassays exhibited biotin-mediated negative interference of approximately 7% in Vitros 5600 and 10% in Roche Elecsys at biotin concentrations of 6 and 15 ng/mL, respectively .
Dilution protocols: Implementing sample dilution protocols can reduce biotin concentration below interference thresholds. This approach must be validated for each assay to ensure linearity and accuracy after dilution.
Alternative binding strategies: Consider alternative assay designs that do not rely on biotin-streptavidin interactions when working with biotinylated proteins or in samples with high biotin concentrations.
Control samples: Include biotin-free control samples to establish baseline assay performance and quantify potential interference effects in experimental samples.
Studying the structural relationships between TROVE2 and biotin-dependent enzymes presents unique challenges due to the large size and complexity of these molecular systems. Effective methodological approaches include:
Cryo-electron microscopy (cryo-EM): The "resolution revolution" in cryo-EM has made it particularly valuable for studying large protein complexes at the atomic level. This technique allows visualization of biotin-dependent carboxylases (500-750 kDa) and their potential interactions with other proteins like TROVE2 without the need for crystallization .
X-ray crystallography optimization: Despite challenges with large complexes, X-ray crystallography remains valuable with appropriate sample optimization. This requires extensive refinement of protein samples and crystallization conditions to obtain diffraction-quality crystals .
Protein-protein interaction assays: Techniques such as co-immunoprecipitation, pull-down assays, and proximity ligation can help characterize the physical interactions between TROVE2 and biotin-dependent enzymes in cellular contexts.
Domain-specific structural analysis: When full-complex structures prove challenging, analyzing the structures of individual domains or subcomplexes can provide valuable insights into potential interaction interfaces.
Integrative structural biology: Combining multiple techniques (cryo-EM, X-ray crystallography, NMR, mass spectrometry) can overcome limitations of individual methods and provide more comprehensive structural information.
TROVE2 is naturally biotinylated in bovine tissues, with the biotinylation potentially influencing its interaction with target Y RNAs . While comprehensive binding kinetics data specific to biotinylated versus non-biotinylated TROVE2 is limited in the provided search results, several methodological considerations are important when investigating this question:
Binding affinity assays: Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) can quantitatively measure differences in binding kinetics between biotinylated and non-biotinylated TROVE2 with Y RNAs.
RNA stability assessment: Since TROVE2 is known to stabilize Y RNAs from degradation, RNA degradation assays comparing the protective effects of biotinylated versus non-biotinylated TROVE2 would provide functional insights.
Structural analysis: Determining whether biotinylation causes conformational changes in TROVE2 that might affect RNA binding sites using techniques such as hydrogen-deuterium exchange mass spectrometry or limited proteolysis.
The biotinylation state of TROVE2 may be particularly relevant when studying autoimmune conditions like SLE, where antibodies react with the normal cellular TROVE2 protein. Researchers should carefully consider how biotinylation might influence antigenic epitopes and antibody recognition in experimental systems .
The connection between biotin metabolism and bovine autoimmune responses involving TROVE2 represents an intriguing research area. While direct evidence linking biotin metabolism to TROVE2-specific autoimmunity is not extensively documented in the provided search results, several experimental approaches can address this question:
Biotin supplementation studies: Investigate whether biotin supplementation alters the incidence or severity of autoimmune responses against TROVE2 in bovine models.
Epitope mapping: Determine whether biotinylation affects the exposure or conformation of immunogenic epitopes on TROVE2 recognized by autoantibodies.
Biotin status correlation: Analyze whether biotin deficiency correlates with increased autoantibody production against TROVE2 in bovine populations.
This research direction is particularly relevant given that sera from patients with Systemic Lupus Erythematosus (SLE) often contain antibodies that react with the normal cellular TROVE2 protein . Understanding how biotin metabolism influences this autoimmune response could provide insights into disease mechanisms and potential therapeutic approaches.
The relationship between biotin requirements, cattle breeds, and TROVE2 expression represents an area requiring further investigation. While systematic comparative data across breeds is not extensively detailed in the provided search results, researchers can approach this question through several methodological strategies:
Cross-breed expression analysis: Implement qPCR or western blot analyses to quantify TROVE2 expression levels across different cattle breeds under standardized conditions.
Biotin supplementation response studies: Compare the effects of identical biotin supplementation protocols across diverse cattle breeds (e.g., Hereford vs. Girolando) to identify breed-specific responses .
Genetic association studies: Identify potential breed-specific genetic variants in biotin metabolism pathways or TROVE2 regulatory regions that might influence expression patterns or biotin requirements.
Tissue-specific expression profiling: Analyze whether tissue-specific expression patterns of TROVE2 vary between breeds, potentially explaining differential responses to biotin supplementation.
Breed | Biotin Dosage | Study Duration | Primary Outcome | Reference |
---|---|---|---|---|
Hereford | 10 mg/head/day | 18 months | 15% vs. 33% vertical fissure prevalence | |
Girolando | 12.5 mg/day | 40 days | 11.3 mm vs. 7.2 mm hoof growth |
Detecting biotinylated TROVE2 in bovine tissue samples requires specialized analytical approaches. Based on research methodologies, the following analytical strategies are recommended:
Protein extraction optimization: Implement tissue-specific extraction protocols using buffers that preserve biotinylation status (20mM Tris/HCl buffer pH-7.5, 150mM NaCl, 2mM MgCl2, 0.2mM DTT, 0.1mM PMSF) .
Western blot analysis: Utilize dual detection strategies with anti-TROVE2 antibodies and streptavidin conjugates to specifically identify biotinylated TROVE2 forms.
Affinity purification: Leverage streptavidin-based affinity purification to enrich biotinylated proteins from complex tissue samples prior to TROVE2-specific detection.
Mass spectrometry: Implement targeted mass spectrometry approaches to identify biotinylated peptides within TROVE2, providing site-specific biotinylation information.
Immunoprecipitation: Combine TROVE2-specific immunoprecipitation with biotin detection methods to isolate and identify biotinylated forms of the protein.
When designing analytical workflows, researchers should consider potential interference from endogenous biotin or biotin-containing proteins in bovine tissues. Additionally, because TROVE2 is purified from bovine tissues using protein-chemical methods and has >80% purity as determined by SDS-PAGE , researchers should implement appropriate controls to ensure specificity of detection.
Emerging research techniques offer new opportunities for investigating TROVE2-biotin interactions in bovine systems. Based on current methodological trends, researchers should consider:
Proximity labeling approaches: Techniques such as BioID or APEX2 proximity labeling can identify proteins that interact with TROVE2 in a biotin-dependent manner in living cells.
Single-molecule imaging: Applying techniques like single-molecule FRET (smFRET) to visualize dynamic interactions between biotinylated TROVE2 and its binding partners in real-time.
Cryo-electron tomography: This technique enables visualization of macromolecular complexes in their native cellular environment, providing insights into TROVE2-biotin interactions within the cellular context.
CRISPR-based approaches: Implementing CRISPR interference or activation systems to modulate TROVE2 expression or biotin-related pathways in bovine cell models.
Integrative multi-omics: Combining proteomics, transcriptomics, and metabolomics approaches to comprehensively characterize how biotin influences TROVE2 function across different physiological conditions.
The "resolution revolution" in cryo-electron microscopy has particularly enhanced our ability to study large protein complexes at the atomic level . This technological advancement offers promising opportunities for elucidating structural relationships between TROVE2 and biotin-dependent carboxylases in bovine systems.
The potential influence of biotin supplementation on TROVE2-related immune responses in cattle presents an intriguing area for future research. While direct evidence connecting these factors is limited in the provided search results, several experimental approaches could address this question:
In vivo supplementation studies: Design longitudinal studies measuring anti-TROVE2 antibody levels in cattle before and after controlled biotin supplementation.
Immune cell functional assays: Assess how biotin supplementation affects the presentation of TROVE2 epitopes by antigen-presenting cells and subsequent T-cell responses.
Cytokine profiling: Measure changes in pro-inflammatory and anti-inflammatory cytokine profiles in response to TROVE2 stimulation under different biotin conditions.
Epitope accessibility analysis: Investigate whether biotin-induced conformational changes in TROVE2 alter the accessibility of immunogenic epitopes recognized by the bovine immune system.
This research direction has potential clinical relevance, given that TROVE2 is recognized as an autoantigen in conditions like Systemic Lupus Erythematosus . Understanding how biotin supplementation might modulate these immune responses could inform nutritional strategies for managing autoimmune conditions in cattle.
TROVE Domain Family Member 2 (TROVE2), also known as Ro60, is a significant protein within the TROVE domain family. This family is primarily involved in RNA binding and stabilization. TROVE2 is a human recombinant protein that is often biotinylated for various research applications.
TROVE2 is a single, non-glycosylated polypeptide chain with a molecular mass of approximately 60 kDa . It is produced in E. coli and can be tagged with biotin to facilitate its use in various biochemical assays . The biotinylation of TROVE2 allows for easy detection and purification using streptavidin-based methods.
The primary function of TROVE2 is to bind several small cytoplasmic RNA molecules known as Y RNAs . This binding helps stabilize these RNAs from degradation, playing a crucial role in maintaining cellular RNA integrity . TROVE2 is also involved in the immune response, as it is recognized by autoantibodies in patients with autoimmune diseases such as Sjögren’s syndrome and systemic lupus erythematosus (SLE) .